Chronic pain affects tens of millions of Americans and its inadequate treatment creates an enormous burden on our health care system, its patients and its clinicians. Gaining a better understanding of the basic mechanisms driving chronic pain has the potential to lead to therapeutics that can reverse chronic pain as opposed to currently available palliative treatments. Changes in gene expression in peripheral sensory neurons link initial injury to the development of chronic pain. Work in this area has focused on transcriptionally-mediated events. However, sensory neurons are large cells with peripheral terminals at great distances from the site of transcription, the nucleus. Hence, control of protein translation potentially affords these cells a mechanism to rapidly change gene expression in direct response to local signaling factors. We have demonstrated, through the previous period of grant support, that translation control indeed plays a vital role in changes in gene expression driving the transition to chronic pain. This discovery creates an important therapeutic opportunity because translation is controlled by a number of kinases (e.g. MNK1/2) which signal to proteins (e.g. eIF4E) involved in the rate-limited step of protein synthesis, translation initiation. We wil test the central hypothesis that translation control signaling is crucial for changes in nociceptor excitability after exposure to pain promoting compounds and for mediating phenotypic changes in nociceptors during the transition to chronic pain. Specifically we will examine a novel signaling pathway for pain plasticity: MNK1/2 kinase phosphorylation of eIF4E. Our hypotheses will be tested through 3 specific aims: 1) MNK1/2 signaling to eIF4E as a key signaling hub for behavioral plasticity leading to chronic pain, 2) MNK1/2 signaling to eIF4E as a critical step for plasticity in nociceptor excitability and 3) BDNF as a key translational target of MNK1/2 - eIF4E signaling in nociceptor phenotypic changes that promote chronic pain. The outcome of the completion of these aims will be an in-depth understanding of how translation regulation promotes nociceptive plasticity, the identification of a specific mechanism (eIF4E phosphorylation) and target (MNK1/2 kinase) as a potential pain therapeutic and novel regulatory mechanisms of BDNF translation and the role of this process in the transition to chronic pain.

Public Health Relevance

Pain is the most prominent reason that Americans seek medical attention and the lifetime population incidence of chronic pain in this country is 33%. This creates an enormous burden on medical care systems and society and leads to human suffering. The goal of our research is to further understand mechanisms driving chronic pain and develop therapeutic strategies to treat and potentially reverse pain based on these molecular insights.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS065926-08
Application #
9412897
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Oshinsky, Michael L
Project Start
2010-03-15
Project End
2019-01-31
Budget Start
2018-02-01
Budget End
2019-01-31
Support Year
8
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of Texas-Dallas
Department
Type
Sch Allied Health Professions
DUNS #
800188161
City
Richardson
State
TX
Country
United States
Zip Code
75080
Moy, Jamie K; Kuhn, Jasper L; Szabo-Pardi, Thomas A et al. (2018) eIF4E phosphorylation regulates ongoing pain, independently of inflammation, and hyperalgesic priming in the mouse CFA model. Neurobiol Pain 4:45-50
Ray, Pradipta; Torck, Andrew; Quigley, Lilyana et al. (2018) Comparative transcriptome profiling of the human and mouse dorsal root ganglia: an RNA-seq-based resource for pain and sensory neuroscience research. Pain 159:1325-1345
Shiers, Stephanie; Pradhan, Grishma; Mwirigi, Juliet et al. (2018) Neuropathic Pain Creates an Enduring Prefrontal Cortex Dysfunction Corrected by the Type II Diabetic Drug Metformin But Not by Gabapentin. J Neurosci 38:7337-7350
Price, Theodore J; Gold, Michael S (2018) From Mechanism to Cure: Renewing the Goal to Eliminate the Disease of Pain. Pain Med 19:1525-1549
Barragán-Iglesias, Paulino; Oidor-Chan, Víctor Hugo; Loeza-Alcocer, Emanuel et al. (2018) Evaluation of the neonatal streptozotocin model of diabetes in rats: Evidence for a model of neuropathic pain. Pharmacol Rep 70:294-303
Price, Theodore J; Basbaum, Allan I; Bresnahan, Jacqueline et al. (2018) Transition to chronic pain: opportunities for novel therapeutics. Nat Rev Neurosci :
Megat, Salim; Shiers, Stephanie; Moy, Jamie K et al. (2018) A Critical Role for Dopamine D5 Receptors in Pain Chronicity in Male Mice. J Neurosci 38:379-397
Black, Bryan J; Atmaramani, Rahul; Kumaraju, Rajeshwari et al. (2018) Adult mouse sensory neurons on microelectrode arrays exhibit increased spontaneous and stimulus-evoked activity in the presence of interleukin-6. J Neurophysiol 120:1374-1385
Shepherd, Andrew J; Copits, Bryan A; Mickle, Aaron D et al. (2018) Angiotensin II Triggers Peripheral Macrophage-to-Sensory Neuron Redox Crosstalk to Elicit Pain. J Neurosci 38:7032-7057
Paige, Candler; Maruthy, Gayathri Batchalli; Mejia, Galo et al. (2018) Spinal Inhibition of P2XR or p38 Signaling Disrupts Hyperalgesic Priming in Male, but not Female, Mice. Neuroscience 385:133-142

Showing the most recent 10 out of 72 publications